Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;164(6):767-78.
doi: 10.1111/bjh.12725. Epub 2014 Jan 9.

Advances in understanding the leukaemia microenvironment

Affiliations
Review

Advances in understanding the leukaemia microenvironment

Yoko Tabe et al. Br J Haematol. 2014 Mar.

Abstract

Dynamic interactions between leukaemic cells and cells of the bone marrow are a feature of haematological malignancies. Two distinct microenvironmental niches in the bone marrow, the 'osteoblastic (endosteal)' and 'vascular' niches, provide a sanctuary for subpopulations of leukaemic cells to evade chemotherapy-induced death and allow acquisition of drug resistance. Key components of the bone marrow microenvironment as a home for normal haematopoietic stem cells and the leukaemia stem cell niches, and the molecular pathways critical for microenvironment/leukaemia interactions via cytokines, chemokines and adhesion molecules as well as hypoxic conditions, are described in this review. Finally, the genetic abnormalities of leukaemia-associated stroma are discussed. Further understanding of the contribution of the bone marrow niche to the process of leukaemogenesis may provide new targets that allow destruction of leukaemia stem cells without adversely affecting normal stem cell self-renewal.

Keywords: bone marrow microenvironment; leukaemia; stem cell niche.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Key components of the leukemic bone marrow microenvironment
Components of normal HSC niches consist of multiple cell types including osteoblasts, Cxcl12-abundant reticular (CAR) cells, nestin-positive mesenchymal stem cells (MSCs), Lepr-expressing perivascular cells, endothelial cells and Schwann cells wrapping sympathetic nerve fibers. LSCs hijack HSC marrow spaces including perivascular and endosteal niches. The BM stromal cells and osteoblasts produce complex extracellular matrix (ECM) such as vascular cell–adhesion molecule-1 (VCAM-1), fibronectin and hyaluronic acid, which facilitate engraftment and adhesion of LSCs. Osteoblasts within endosteal niches generate transforming growth factor-β (TGF-β), angiopoietin-1 (Ang-1) and Jagged-1 (Jag-1) that in turn promote leukemia cells dormancy and decrease their chemosensitivity. CAR cells, nestin-positive MSCs, Leptin receptor-positive perivascular cells, and endothelial cells may play role for leukemia cells migration to perivascular microenvironment via cytokines, chemokines, and adhesion molecules. Inhibition of leukemia / stroma interactions causes increased leukemia cells cycling and homing to perivascular niches which can potentially be used for chemosensitization to target domant LSCs.

Similar articles

Cited by

References

    1. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006;439:599–603. - PubMed
    1. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118:149–161. - PubMed
    1. Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, Kollet O, Hershkoviz R, Alon R, Hardan I, Ben-Hur H, Naor D, Nagler A, Lapidot T. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood. 2004;103:2981–2989. - PubMed
    1. Benito J, Shi Y, Szymanska B, Carol H, Boehm I, Lu H, Konoplev S, Fang W, Zweidler-McKay PA, Campana D, Borthakur G, Bueso-Ramos C, Shpall E, Thomas DA, Jordan CT, Kantarjian H, Wilson WR, Lock R, Andreeff M, Konopleva M. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS One. 2011;6:e23108. - PMC - PubMed
    1. Bonig H, Papayannopoulou T. Hematopoietic stem cell mobilization: updated conceptual renditions. Leukemia. 2013;27:24–31. - PMC - PubMed